BioStem Technologies reported $7.6 million in Q3 2026 revenue, with hospital revenue rising to $6.8 million. The company saw a 14% increase in customers buying multiple product lines and is on track to start in-house production of Neox and Clarix in early 2027. BioStem raised its full-year 2026 revenue guidance to $28-29 million and is focusing on cost reductions and improving profitability. The company also secured $3 million from a private placement and is working to restructure debt and reduce expenses.
BioStem Technologies reported $7.6 million in Q3 2026 revenue, highlighting growth in hospital revenue to $6.8 million as customers expand product use. For readers following the health sector, here is Pluang's market snapshot as of Nov 13, 2026 04:11 WIB: out of 150 priced US health stocks, 23 rose and 124 fell. Notable movers include RXRX at USD 3.34 with a -6.96% change, HRTX at USD 0.33 down 6.90%, and TWST at USD 114.14 down 6.89%, with typical hold times ranging from 23 to 39 days and mixed Pluang order activity.
Siemens reported earnings per share of $1.62 and revenue of $26.28 billion, both exceeding analyst expectations. The company saw record orders and double-digit revenue growth in its smart infrastructure and digital industries units, prompting it to r...
ASUS has introduced a broad ecosystem of AI-ready hardware and software designed for gamers, creators, developers, and enterprises. The ASUS Agent Computer initiative enables users to deploy AI locally, in the cloud, or via hybrid models, offering co...
The global cosmetic peptide synthesis market is projected to grow from $274 million in 2027 to $354.85 million by 2032, with a CAGR of 5.34%. Growth is fueled by rising demand for advanced anti-aging skincare ingredients, increased use of peptide-bas...
Cisco is set to report its fiscal Q1 2027 earnings with a focus on cloud growth and AI demand. Analysts expect revenue around $18.1 billion, operating income of $6.5 billion, and earnings per share of $1.33, reflecting strong year-over-year growth. T...
BASF has agreed to sell its global mining solutions business to SNF, a specialty chemical company based in France, following a strategic review of BASF's Performance Chemicals division. The deal includes BASF's mining chemicals portfolio, production ...
